Prenatal diagnosis of fetal aneuploidies: post-genomic developments.

Abstract:

:Prenatal diagnosis of fetal aneuploidies and chromosomal anomalies is likely to undergo a profound change in the near future. On the one hand this is mediated by new technical developments, such as chromosomal microarrays, which allow a much more precise delineation of minute sub-microscopic chromosomal aberrancies than the classical G-band karyotype. This will be of particular interest when investigating pregnancies at risk of unexplained development delay, intellectual disability or certain forms of autism. On the other hand, great strides have been made in the non-invasive determination of fetal genetic traits, largely through the analysis of cell-free fetal nucleic acids. It is hoped that, with the assistance of cutting-edge tools such as digital PCR or next generation sequencing, the long elusive goal of non-invasive prenatal diagnosis for fetal aneuploidies can finally be attained.

journal_name

Genome Med

journal_title

Genome medicine

authors

Hahn S,Jackson LG,Zimmermann BG

doi

10.1186/gm171

subject

Has Abstract

pub_date

2010-08-05 00:00:00

pages

50

issue

8

issn

1756-994X

pii

gm171

journal_volume

2

pub_type

杂志文章
  • DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma.

    abstract:BACKGROUND:Organic cation transporters (OCTs) determine not only physiological processes but are also involved in the cellular uptake of anticancer agents. Based on microarray analyses in hepatocellular carcinoma (HCC), SLC22A1/OCT1 mRNA seems to be downregulated, but systematic protein expression data are currently mi...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm298

    authors: Schaeffeler E,Hellerbrand C,Nies AT,Winter S,Kruck S,Hofmann U,van der Kuip H,Zanger UM,Koepsell H,Schwab M

    更新日期:2011-12-23 00:00:00

  • Precision cancer mouse models through genome editing with CRISPR-Cas9.

    abstract::The cancer genome is highly complex, with hundreds of point mutations, translocations, and chromosome gains and losses per tumor. To understand the effects of these alterations, precise models are needed. Traditional approaches to the construction of mouse models are time-consuming and laborious, requiring manipulatio...

    journal_title:Genome medicine

    pub_type: 杂志文章,评审

    doi:10.1186/s13073-015-0178-7

    authors: Mou H,Kennedy Z,Anderson DG,Yin H,Xue W

    更新日期:2015-06-09 00:00:00

  • Staging of biliary atresia at diagnosis by molecular profiling of the liver.

    abstract:BACKGROUND:Young age at portoenterostomy has been linked to improved outcome in biliary atresia, but pre-existing biological factors may influence the rate of disease progression. In this study, we aimed to determine whether molecular profiling of the liver identifies stages of disease at diagnosis. METHODS:We examine...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm154

    authors: Moyer K,Kaimal V,Pacheco C,Mourya R,Xu H,Shivakumar P,Chakraborty R,Rao M,Magee JC,Bove K,Aronow BJ,Jegga AG,Bezerra JA

    更新日期:2010-05-13 00:00:00

  • Functional profiling of the gut microbiome in disease-associated inflammation.

    abstract::The microbial residents of the human gut are a major factor in the development and lifelong maintenance of health. The gut microbiota differs to a large degree from person to person and has an important influence on health and disease due to its interaction with the human immune system. Its overall composition and mic...

    journal_title:Genome medicine

    pub_type: 杂志文章,评审

    doi:10.1186/gm469

    authors: Börnigen D,Morgan XC,Franzosa EA,Ren B,Xavier RJ,Garrett WS,Huttenhower C

    更新日期:2013-07-31 00:00:00

  • Use of semantic workflows to enhance transparency and reproducibility in clinical omics.

    abstract:BACKGROUND:Recent highly publicized cases of premature patient assignment into clinical trials, resulting from non-reproducible omics analyses, have prompted many to call for a more thorough examination of translational omics and highlighted the critical need for transparency and reproducibility to ensure patient safet...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-015-0202-y

    authors: Zheng CL,Ratnakar V,Gil Y,McWeeney SK

    更新日期:2015-07-25 00:00:00

  • Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations.

    abstract:BACKGROUND:Chemotherapeutic agents such as anthracyclines and taxanes are commonly used in the neoadjuvant setting. Bevacizumab is an antibody which binds to vascular endothelial growth factor A (VEGFA) and inhibits its receptor interaction, thus obstructing the formation of new blood vessels. METHODS:A phase II rando...

    journal_title:Genome medicine

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1186/s13073-018-0601-y

    authors: Höglander EK,Nord S,Wedge DC,Lingjærde OC,Silwal-Pandit L,Gythfeldt HV,Vollan HKM,Fleischer T,Krohn M,Schlitchting E,Borgen E,Garred Ø,Holmen MM,Wist E,Naume B,Van Loo P,Børresen-Dale AL,Engebraaten O,Kristensen V

    更新日期:2018-11-29 00:00:00

  • NGS-Logistics: federated analysis of NGS sequence variants across multiple locations.

    abstract::As many personal genomes are being sequenced, collaborative analysis of those genomes has become essential. However, analysis of personal genomic data raises important privacy and confidentiality issues. We propose a methodology for federated analysis of sequence variants from personal genomes. Specific base-pair posi...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-014-0071-9

    authors: Ardeshirdavani A,Souche E,Dehaspe L,Van Houdt J,Vermeesch JR,Moreau Y

    更新日期:2014-09-17 00:00:00

  • Biomarker discovery in human cerebrospinal fluid: the need for integrative metabolome and proteome databases.

    abstract::The number of metabolites identified in human cerebrospinal fluid (CSF) has steadily increased over the past 5 years, and in this issue of Genome Medicine David Wishart and colleagues provide a comprehensive update that brings the number of metabolites listed in the CSF metabolome database to 476 compounds. There is n...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm338

    authors: Schwarz E,Torrey EF,Guest PC,Bahn S

    更新日期:2012-04-30 00:00:00

  • Network-based approaches elucidate differences within APOBEC and clock-like signatures in breast cancer.

    abstract:BACKGROUND:Studies of cancer mutations have typically focused on identifying cancer driving mutations that confer growth advantage to cancer cells. However, cancer genomes accumulate a large number of passenger somatic mutations resulting from various endogenous and exogenous causes, including normal DNA damage and rep...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00745-2

    authors: Kim YA,Wojtowicz D,Sarto Basso R,Sason I,Robinson W,Hochbaum DS,Leiserson MDM,Sharan R,Vadin F,Przytycka TM

    更新日期:2020-05-29 00:00:00

  • Optimizing the treatment of BRAF mutant melanoma.

    abstract::Selective inhibitors of the kinases BRAF and MEK for the treatment of patients with otherwise refractory BRAF mutant melanoma have demonstrated impressive efficacy, and combination treatment with these agents may prove to be even more effective. However, these drugs are not curative, mainly because of the relatively r...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm547

    authors: Settleman J

    更新日期:2014-04-28 00:00:00

  • Ultradeep analysis of tumor heterogeneity in regions of somatic hypermutation.

    abstract::Tumor heterogeneity is of growing importance in the treatment of cancers. Mutational hot spots are prime locations for determining number and proportions of low variant allele frequency (VAF) tumor subclones by next generation sequencing. Low VAF detection is complicated by poor mapping efficiency in regions with high...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-015-0147-1

    authors: Spence JM,Spence JP,Abumoussa A,Burack WR

    更新日期:2015-03-12 00:00:00

  • Personalizing carbamazepine therapy.

    abstract::The anticonvulsant carbamazepine has a high incidence of cutaneous adverse drug reactions. A recent prospective clinical trial in Taiwan has indicated that HLA-B*1502 screening will reduce the incidence of life-threatening adverse reactions to carbamazepine, while a genome-wide association study has identified the HLA...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm243

    authors: Mushiroda T,Nakamura Y

    更新日期:2011-05-30 00:00:00

  • Host genetic variation and its microbiome interactions within the Human Microbiome Project.

    abstract:BACKGROUND:Despite the increasing recognition that microbial communities within the human body are linked to health, we have an incomplete understanding of the environmental and molecular interactions that shape the composition of these communities. Although host genetic factors play a role in these interactions, these...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-018-0515-8

    authors: Kolde R,Franzosa EA,Rahnavard G,Hall AB,Vlamakis H,Stevens C,Daly MJ,Xavier RJ,Huttenhower C

    更新日期:2018-01-29 00:00:00

  • From small studies to precision medicine: prioritizing candidate biomarkers.

    abstract::There are still many open questions in data-analytic research pertaining to biomarker development in the era of personalized/precision medicine and big data. Among them is the question of what constitutes best practice for the extraction of prioritized lists of candidate biomarkers from smaller studies that are 'hypot...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm507

    authors: Gaile DP,Miecznikowski JC

    更新日期:2013-11-29 00:00:00

  • A population-based gene expression signature of molecular clock phase from a single epidermal sample.

    abstract:BACKGROUND:For circadian medicine to influence health, such as when to take a drug or undergo a procedure, a biomarker of molecular clock phase is required--one that is easily measured and generalizable across a broad population. It is not clear that any circadian biomarker yet satisfies these criteria. METHODS:We ana...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00768-9

    authors: Wu G,Ruben MD,Francey LJ,Smith DF,Sherrill JD,Oblong JE,Mills KJ,Hogenesch JB

    更新日期:2020-08-21 00:00:00

  • Phylogenetically informative mutations in genes implicated in antibiotic resistance in Mycobacterium tuberculosis complex.

    abstract:BACKGROUND:A comprehensive understanding of the pre-existing genetic variation in genes associated with antibiotic resistance in the Mycobacterium tuberculosis complex (MTBC) is needed to accurately interpret whole-genome sequencing data for genotypic drug susceptibility testing (DST). METHODS:We investigated mutation...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-020-00726-5

    authors: Merker M,Kohl TA,Barilar I,Andres S,Fowler PW,Chryssanthou E,Ängeby K,Jureen P,Moradigaravand D,Parkhill J,Peacock SJ,Schön T,Maurer FP,Walker T,Köser C,Niemann S

    更新日期:2020-03-06 00:00:00

  • Text-mining clinically relevant cancer biomarkers for curation into the CIViC database.

    abstract:BACKGROUND:Precision oncology involves analysis of individual cancer samples to understand the genes and pathways involved in the development and progression of a cancer. To improve patient care, knowledge of diagnostic, prognostic, predisposing, and drug response markers is essential. Several knowledgebases have been ...

    journal_title:Genome medicine

    pub_type: 杂志文章,meta分析

    doi:10.1186/s13073-019-0686-y

    authors: Lever J,Jones MR,Danos AM,Krysiak K,Bonakdar M,Grewal JK,Culibrk L,Griffith OL,Griffith M,Jones SJM

    更新日期:2019-12-03 00:00:00

  • Moving pathogen genomics out of the lab and into the clinic: what will it take?

    abstract::Pathogen genomic analysis is a potentially transformative new approach to the clinical and public-health management of infectious diseases. Health systems investing in this technology will need to build infrastructure and develop policies that ensure genomic information can be generated, shared and acted upon in a tim...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-015-0254-z

    authors: Luheshi LM,Raza S,Peacock SJ

    更新日期:2015-12-30 00:00:00

  • Moderate- to low-risk variant alleles of cutaneous malignancies and nevi: lessons from genome-wide association studies.

    abstract::Cutaneous malignancies, especially malignant melanoma, exhibit great genetic heterogeneity. As a result, some individuals and families have particularly increased risk due to genetic predisposition to the disease. The susceptibility alleles range from rarely occurring, heritable, high-risk variants to ubiquitously occ...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm95

    authors: Udayakumar D,Tsao H

    更新日期:2009-10-27 00:00:00

  • De novo truncating mutations in ASXL3 are associated with a novel clinical phenotype with similarities to Bohring-Opitz syndrome.

    abstract:BACKGROUND:Molecular diagnostics can resolve locus heterogeneity underlying clinical phenotypes that may otherwise be co-assigned as a specific syndrome based on shared clinical features, and can associate phenotypically diverse diseases to a single locus through allelic affinity. Here we describe an apparently novel s...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm415

    authors: Bainbridge MN,Hu H,Muzny DM,Musante L,Lupski JR,Graham BH,Chen W,Gripp KW,Jenny K,Wienker TF,Yang Y,Sutton VR,Gibbs RA,Ropers HH

    更新日期:2013-02-05 00:00:00

  • Bridging the gap between systems biology and medicine.

    abstract::Systems biology has matured considerably as a discipline over the last decade, yet some of the key challenges separating current research efforts in systems biology and clinically useful results are only now becoming apparent. As these gaps are better defined, the new discipline of systems medicine is emerging as a tr...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm88

    authors: Clermont G,Auffray C,Moreau Y,Rocke DM,Dalevi D,Dubhashi D,Marshall DR,Raasch P,Dehne F,Provero P,Tegner J,Aronow BJ,Langston MA,Benson M

    更新日期:2009-09-29 00:00:00

  • Exploiting the noise: improving biomarkers with ensembles of data analysis methodologies.

    abstract:BACKGROUND:The advent of personalized medicine requires robust, reproducible biomarkers that indicate which treatment will maximize therapeutic benefit while minimizing side effects and costs. Numerous molecular signatures have been developed over the past decade to fill this need, but their validation and up-take into...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm385

    authors: Starmans MH,Pintilie M,John T,Der SD,Shepherd FA,Jurisica I,Lambin P,Tsao MS,Boutros PC

    更新日期:2012-11-12 00:00:00

  • Killer-cell Immunoglobulin-like Receptor gene linkage and copy number variation analysis by droplet digital PCR.

    abstract::The Killer-cell Immunoglobulin-like Receptor (KIR) gene complex has considerable biomedical importance. Patterns of polymorphism in the KIR region include variability in the gene content of haplotypes and diverse structural arrangements. Droplet digital PCR (ddPCR) was used to identify different haplotype motifs and t...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm537

    authors: Roberts CH,Jiang W,Jayaraman J,Trowsdale J,Holland MJ,Traherne JA

    更新日期:2014-03-05 00:00:00

  • Back to the family: a renewed approach to rare variant studies.

    abstract::A report on the 62nd Annual Meeting of the American Society of Human Genetics, San Francisco, California, USA, 6-10 November 2012. ...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm398

    authors: Zielinski D,Gymrek M,Erlich Y

    更新日期:2012-12-19 00:00:00

  • Virulence genes are a signature of the microbiome in the colorectal tumor microenvironment.

    abstract:BACKGROUND:The human gut microbiome is associated with the development of colon cancer, and recent studies have found changes in the microbiome in cancer patients compared to healthy controls. Studying the microbial communities in the tumor microenvironment may shed light on the role of host-bacteria interactions in co...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/s13073-015-0177-8

    authors: Burns MB,Lynch J,Starr TK,Knights D,Blekhman R

    更新日期:2015-06-24 00:00:00

  • Stem cell banking: between traceability and identifiability.

    abstract::Stem cell banks are increasingly seen as an essential resource of biological materials for both basic and translational research. Stem cell banks support transnational access to quality-controlled and ethically sourced stem cell lines from different origins and of varying grades. According to the Organisation for Econ...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm194

    authors: Knoppers BM,Isasi R

    更新日期:2010-10-05 00:00:00

  • Pancreatic cancer genomics: insights and opportunities for clinical translation.

    abstract::Pancreatic cancer is a highly lethal tumor type for which there are few viable therapeutic options. It is also caused by the accumulation of mutations in a variety of genes. These genetic alterations can be grouped into those that accumulate during pancreatic intraepithelial neoplasia (precursor lesions) and thus are ...

    journal_title:Genome medicine

    pub_type: 杂志文章,评审

    doi:10.1186/gm430

    authors: Makohon-Moore A,Brosnan JA,Iacobuzio-Donahue CA

    更新日期:2013-03-28 00:00:00

  • Mining the literature: new methods to exploit keyword profiles.

    abstract:UNLABELLED:Bibliographic records in the PubMed database of biomedical literature are annotated with Medical Subject Headings (MeSH) by curators, which summarize the content of the articles. Two recent publications explain how to generate profiles of MeSH terms for a set of bibliographic records and to use them to defin...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm382

    authors: Andrade-Navarro MA

    更新日期:2012-10-30 00:00:00

  • Estimating exome genotyping accuracy by comparing to data from large scale sequencing projects.

    abstract::With exome sequencing becoming a tool for mutation detection in routine diagnostics there is an increasing need for platform-independent methods of quality control. We present a genotype-weighted metric that allows comparison of all the variant calls of an exome to a high-quality reference dataset of an ethnically mat...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm473

    authors: Heinrich V,Kamphans T,Stange J,Parkhomchuk D,Hecht J,Dickhaus T,Robinson PN,Krawitz PM

    更新日期:2013-07-31 00:00:00

  • PPAR action in insulin resistance unraveled by metabolomics: potential clinical implications.

    abstract::Metabolomic analysis will provide the next large set of clues to further our understanding of human health and disease. A recent study has elucidated the significant differences in the metabolomes of adipocytes, serum and an adipocyte cell line after activation of two nuclear receptors, peroxisome proliferator activat...

    journal_title:Genome medicine

    pub_type: 杂志文章

    doi:10.1186/gm270

    authors: Patterson AD,Peters JM

    更新日期:2011-08-23 00:00:00